Weave Communications, Inc. (NYSE: WEAV)

Sector: Healthcare Industry: Health Information Services CIK: 0001609151
Market Cap 529.63 Mn
P/B 6.74
P/E -16.09
P/S 2.30
ROIC (Qtr) -27.26
Div Yield % 0.00
Rev 1y % (Qtr) 17.10
Total Debt (Qtr) 53.05 Mn
Debt/Equity (Qtr) 0.67

About

Weave Communications, Inc., often referred to as Weave, is a prominent player in the realm of all-in-one customer experience and payments software platforms, specifically catering to small and medium-sized businesses in the healthcare sector. The company's core mission revolves around elevating the patient experience, a feat achieved by providing a unified platform that streamlines business operations and allows healthcare professionals to focus on patient care. Weave's platform is meticulously designed to address the unique needs of various industry...

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 64.39M provide 5.83x coverage of short-term debt 11.05M, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 169.52M provides 3.20x coverage of total debt 53.05M, indicating robust asset backing and low credit risk.
  • Operating cash flow of 17.97M provides exceptional 10.57x coverage of interest expenses 1.70M, showing strong debt service capability.
  • Robust free cash flow of 14.59M exceeds capital expenditure of 3.38M by 4.31x, indicating strong organic growth funding capability.
  • Robust tangible asset base of 169.52M provides 8.46x coverage of working capital 20.04M, indicating strong operational backing.

Bear case

  • Investment activities of 5.10M provide weak support for R&D spending of 47.02M, which is 0.11x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Cash reserves of 64.39M provide limited coverage of acquisition spending of (23.86M), which is -2.70x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating cash flow of 17.97M provides insufficient coverage of deferred revenue obligations of 38.50M, which is 0.47x, raising concerns about future service delivery capabilities.
  • The company's operating cash flow of 17.97M shows concerning coverage of stock compensation expenses of 37.29M, with a 0.48 ratio indicating potential earnings quality issues.
  • Operating cash flow of 17.97M provides minimal -20.28x coverage of tax expenses of (886000), suggesting potential tax planning inefficiencies or unsustainable tax positions.

Peer comparison

Companies in the Health Information Services
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TEM Tempus AI, Inc. 45.63 Bn -223.83 41.29 1.34 Bn
2 GEHC GE HealthCare Technologies Inc. 38.75 Bn 19.85 2.19 10.28 Bn
3 VEEV Veeva Systems Inc 37.30 Bn 43.36 12.11 0.09 Bn
4 DOCS Doximity, Inc. 7.81 Bn 30.87 12.57 0.01 Bn
5 BTSG BrightSpring Health Services, Inc. 7.70 Bn 59.42 0.62 2.70 Bn
6 HQY Healthequity, Inc. 7.32 Bn 38.14 5.67 1.03 Bn
7 WAY Waystar Holding Corp. 5.00 Bn 44.97 4.81 1.25 Bn
8 PRVA Privia Health Group, Inc. 2.79 Bn 153.67 1.37 0.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 2.61 2.77
EV to Cash from Ops. EV/CFO 30.04 -10.86
EV to Debt EV to Debt 10.17 161.93
EV to EBIT EV/EBIT -16.81 -106.48
EV to EBITDA EV/EBITDA -27.13 4.22
EV to Free Cash Flow [EV/FCF] EV/FCF 37.00 7.46
EV to Market Cap EV to Market Cap 1.02 -14.93
EV to Revenue EV/Rev 2.35 1.76
Price to Book Value [P/B] P/B 6.74 10.57
Price to Earnings [P/E] P/E -16.09 147.14
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.00 -8.65
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 5.00
Dividend per Basic Share Div per Share (Qtr) 0.00 0.04
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 4.57
Interest Coverage Int. cover (Qtr) -18.88 -584.72
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 16.37 -24.09
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 26.01 172.48
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -1.05
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -15.35 -17.73
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -21.25 39.85
EBIT Growth (1y) % EBIT 1y % (Qtr) -19.43 -38.83
EBT Growth (1y) % EBT 1y % (Qtr) -18.85 -4.52
EPS Growth (1y) % EPS 1y % (Qtr) -10.00 2.60
FCF Growth (1y) % FCF 1y % (Qtr) 103.35 -48.57
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 19.41 5.49
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.11 0.66
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.03
Cash Ratio Cash Ratio (Qtr) 0.78 1.87
Current Ratio Curr Ratio (Qtr) 1.24 3.27
Debt to Equity Ratio Debt/Equity (Qtr) 0.67 -0.43
Interest Cover Ratio Int Coverage (Qtr) -18.88 -584.72
Times Interest Earned Times Interest Earned (Qtr) -18.88 -584.72
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -7.00 -435.80
EBIT Margin % EBIT Margin % (Qtr) -13.97 -464.70
EBT Margin % EBT Margin % (Qtr) -14.71 -461.74
Gross Margin % Gross Margin % (Qtr) 71.90 44.03
Net Profit Margin % Net Margin % (Qtr) -14.30 -468.01